Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
GEN Roundup: Multiplex Immunoassays Bring the Array, Not the Disarray
Get Multiplex Immunoassay Advice from GEN's Expert Panel
For full access to this article login to GEN Select now.
Leveling Downstream Process Bottlenecks
Alternatives to Traditional Unit Operations Are Now Available to Alleviate Very Real Logjams
- Due to the complexity of therapeutic protein purification, downstream bioprocess bottlenecks can arise from almost anywhere, from capacity or facility mismatches to scheduling. Although their sources and bottom-line impact may be debated, bottlenecks are real and their alleviation has become a significant activity, to the point where companies are ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.